Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is recruiting in the United States. It is testing Efficacy of AXS-05 Compared to Bupropion for depression.
Multiple locations, including BellflowerThis study is recruiting in China. It is testing Efficacy, Safety, and Pharmacokinetic Characteristics of (R)-Ketamine Hydrochloride Nasal Spray for depression.
Multiple locations, including BeijingThis study is recruiting in the United States, in France, in Canada, .... It is testing KarXT and KarX-EC for schizophrenia.
Multiple locations, including Anaheim
This study is recruiting in the United States, in Australia, in Canada, .... It is testing Maintenance Effect of NBI-1065845 for depression.
Multiple locations, including OceansideThis study is recruiting in the United Kingdom. It is testing NTX-1955 for anxiety.
In United KingdomThis study is recruiting in the United States. It focuses on Schizophrenia.
Multiple locations, including Los Alamitos
This study is recruiting in the United States. It is testing TNX-102 SL Monotherapy for depression.
Multiple locations, including PhoenixThis study is recruiting in the United Kingdom. It focuses on Anxiety.
In United KingdomThis study is recruiting in the United Kingdom. It focuses on depression.
In United KingdomThis study is recruiting. It focuses on anxiety and currently lists participation information in Colombia.
In ColombiaThis study is recruiting in Bolivia and in Guatemala. It focuses on Anxiety.
In BoliviaThis study is recruiting in the United States. It focuses on Bipolarity.
In BostonHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.